Page 30 - AN-2-3
P. 30

Advanced Neurology                                                       The role of gut in multiple sclerosis



            80.  Tankou SK, Regev K, Healy BC,  et al., 2018. A  probiotic   modulate ongoing autoimmune neurological disease.
               modulates the microbiome and immunity in multiple   J Neuroinflammation, 17: 79.
               sclerosis. Ann Neurol, 83: 1147–1161.
                                                                  https://doi.org/10.1186/s12974-020-01766-9
               https://doi.org/10.1002/ana.25244
                                                               90.  Chen  H, Ma  X, Liu  Y,  et al., 2019,  Gut microbiota
            81.  Abdurasulova IN, Matsulevich AV, Tarasova EA,  et al.,   interventions with Clostridium butyricum and norfloxacin
               2016, Enterococcus faecium strain L-3 and glatiramer acetate   modulate immune response in experimental autoimmune
               ameliorate experimental allergic encephalomyelitis in rats   encephalomyelitis mice. Front Immunol, 10: 1662.
               by affecting different populations of immune cells.  Benef      https://doi.org/10.3389/fimmu.2019.01662
               Microbes, 7: 719–729.
                                                               91.  Minagar A, Alexander JS, Schwendimann RN,  et  al.,
               https://doi.org/10.3920/BM2016.0018                2008,  Combination  therapy  with interferon beta-1a  and
            82.  Secher  T,  Kassem  S,  Benamar  M,  et al.,  2017,  Oral   doxycycline in multiple sclerosis: An open-label trial. Arch
               administration of the probiotic strain Escherichia coli Nissle   Neurol, 65: 199–204.
               1917 reduces susceptibility to neuroinflammation and repairs      https://doi.org/10.1001/archneurol.2007.41
               experimental  autoimmune  encephalomyelitis-induced
               intestinal barrier dysfunction. Front Immunol, 8: 1096.   92.  Mazdeh M, Mobaien AR, 2012, Efficacy of doxycycline
                                                                  as add-on to interferon beta-1a in treatment of multiple
               https://doi.org/10.3389/fimmu.2017.01096           sclerosis. Iran J Neurol, 11: 70–73.
            83.  He  B,  Hoang  TK,  Tian  X,  et al.,  2019,  Lactobacillus   93.  Metz LM, Eliasziw M, 2017, Trial of minocycline in
               reuteri reduces the severity of experimental autoimmune   clinically isolated syndrome of multiple sclerosis. N Engl J
               encephalomyelitis in mice by modulating gut microbiota.   Med, 377: 789.
               Front Immunol, 10: 385.
                                                                  https://doi.org/10.1056/NEJMc1708486
               https://doi.org/10.3389/fimmu.2019.00385
                                                               94.  Ross  CL,  Spinler  JK,  Savidge  TC,  2016,  Structural  and
            84.  Kouchaki E, Tamtaji OR, Salami M, et al., 2017, Clinical and   functional changes within the gut microbiota and
               metabolic response to probiotic supplementation in patients   susceptibility to  Clostridium  difficile infection.  Anaerobe,
               with multiple sclerosis: A  randomized, double-blind,   41: 37–43.
               placebo-controlled trial. Clin Nutr, 36: 1245–1249.
                                                                  https://doi.org/10.1016/j.anaerobe.2016.05.006
               https://doi.org/10.1016/j.clnu.2016.08.015
                                                               95.  Zmora N, Suez J, Elinav E, 2019, You are what you eat:
            85.  Tamtaji OR, Kouchaki E, Salami M, et al., 2017, The effects   Diet, health and the gut microbiota. Nat Rev Gastroenterol
               of probiotic supplementation on gene expression related to   Hepatol, 16: 35–56.
               inflammation, insulin, and lipids in patients with multiple
               sclerosis: A  randomized, double-blind,  placebo-controlled      https://doi.org/10.1038/s41575-018-0061-2
               trial. J Am Coll Nutr, 36: 660–665.             96.  Sonnenburg ED, Smits SA, Tikhonov M, et al., 2016, Diet-
               https://doi.org/10.1080/07315724.2017.1347074      induced extinctions in the gut microbiota compound over
                                                                  generations. Nature, 529: 212–215.
            86.  Miyauchi E, Kim SW, Suda W,  et al., 2020, Gut
               microorganisms act together to exacerbate inflammation in      https://doi.org/10.1038/nature16504
               spinal cords. Nature, 585: 102–106.             97.  Sonnenburg  JL,  Backhed  F,  2016,  Diet-microbiota
               https://doi.org/10.1038/s41586-020-2634-9          interactions as moderators of human metabolism. Nature,
                                                                  535: 56–64.
            87.  Montgomery TL, Künstner A, Kennedy JJ,  et al., 2020,
               Interactions between host genetics and gut microbiota      https://doi.org/10.1038/nature18846
               determine susceptibility to CNS autoimmunity.  Proc  Natl   98.  Kap YS, Bus-Spoor C, van Driel N, et al., 2018, Targeted diet
               Acad Sci U S A, 117: 27516–27527.                  modification reduces multiple sclerosis-like disease in adult
               https://doi.org/10.1073/pnas.2002817117            marmoset monkeys from an outbred colony.  J  Immunol,
                                                                  201: 3229–3243.
            88.  Mestre L, Carrillo-Salinas FJ, Mecha M,  et al., 2019,
               Manipulation  of  gut  microbiota  influences  immune      https://doi.org/10.4049/jimmunol.1800822
               responses, axon preservation, and motor disability in a   99.  Cignarella F, Cantoni C, Ghezzi L, et al., 2018, Intermittent
               model of progressive multiple sclerosis.  Front Immunol,   fasting confers protection in CNS autoimmunity by altering
               10: 1374.                                          the gut microbiota. Cell Metab, 27: 1222–1235.e6.
               https://doi.org/10.3389/fimmu.2019.01374           https://doi.org/10.1016/j.cmet.2018.05.006
            89.  Gödel C, Kunkel B, Kashani A,  et al., 2020, Perturbation   100.  Saresella M, Mendozzi L, Rossi V, et al., 2017, Immunological
               of gut microbiota decreases susceptibility but does not   and clinical effect of diet modulation of the gut microbiome in


            Volume 2 Issue 3 (2023)                         13                         https://doi.org/10.36922/an.413
   25   26   27   28   29   30   31   32   33   34   35